Abstract: Emphysematous pancreatitis (EP) is a subtype of acute necrotizing pancreatitis (ANP) characterized by the presence of gas in and around the pancreas. Although investigators have studied prognostic factors in ANP, less is known about EP. We aimed to determine predictors of mortality and identify changes in management strategies for EP. A PubMed search was performed to identify EP cases. Data were gathered about patient demographics, clinical findings, laboratory results, radiological studies, procedures, outcomes, and mortality. Data were analyzed using univariate and multivariate logistic regression analyses. Including a case from our institution, the study cohort included 64 subjects. The overall mortality rate was 32.8% (21/64). On univariate analysis, age (P = 0.019), hypotension (P = 0.007), gas outside the pancreas on computed tomography imaging (P = 0.003), initial surgical evacuation (P = 0.007), and the development of multiorgan failure (P = 0.008) were associated with mortality. On multivariate analysis, only the development of multiorgan failure was found to be an independent predictor of mortality (P = 0.039). The overall mortality rate of 32.8% for EP is similar to the mortality rates published for ANP. The development of multiorgan failure in EP is strongly associated with increased mortality. Percutaneous and endoscopic approaches have been replacing surgical interventions.
A cute pancreatitis (AP) is responsible for approximately 1.2 million emergency room visits per year in the United States, and approximately 75% of these patients will require admission. 1 The estimated annual cost associated with hospitalizations for AP is approximately $2 billion per year. 1 The diagnosis of acute pancreatitis depends on the presence of 2 of 3 criteria: imaging suggestive of acute pancreatitis, serum amylase and/or lipase greater than 3 times the upper limit of normal, and epigastric abdominal pain suggesting pancreatic involvement. 2 Although most cases of acute pancreatitis will resolve with conservative management and pain control, up to 20% of patients hospitalized with AP will develop severe disease defined as persistent organ failure lasting more than 48 hours. 2 Although several prognostic criteria have been developed to predict disease severity such as the Balthazar 3 and Ranson 4 scoring systems, bedside index for severity in acute pancreatitis score, 5 Acute Physiology and Chronic Health Evaluation II score, 6 and the recently modified Marshall criteria, 2,3 these scoring systems have not been uniformly clinically accepted. When necrosis of the pancreas is found on imaging, the case can become classified as acute necrotizing pancreatitis (ANP). Studies have shown that patients with ANP tend to have longer hospital stay and greater morbidity and mortality compared with patients with interstitial edematous pancreatitis. 7, 8 Furthermore, previous investigations have demonstrated that the percentage of pancreatic necrosis correlated with decreased survival 9 and multiorgan failure in the setting of pancreatic sepsis. Approximately 10% to 40% of patients with ANP will have infected tissue. 10 When infection and necrosis are both present, mortality rates can be as high as 50% to 70%. 11, 12 Emphysematous pancreatitis (EP) is a subtype of ANP where gas is present in and around the infected necrotic pancreas. [13] [14] [15] Although individual case reports and case series of EP have been published in the literature with a mortality rate of 10% 14 to 36%, 16 no systemic analysis has yet been performed to characterize this patient population and to identify risk factors associated with mortality. We hypothesized that the presence of organ dysfunction (a surrogate for severe injury) would be associated with increased mortality, whereas nonsurgical interventions (endoscopic and percutaneous) would be associated with decreased mortality. We performed a systematic analysis, including the data from a recent case at our institution, to test our hypothesis and better define clinical features of EP, identify predictors of mortality, and determine the impact of nonsurgical interventions.
CASE REPORT
A 55-year-old man with a history of insulin-dependent diabetes mellitus, cholelithiasis requiring cholecystectomy, appendectomy, and alcohol-induced pancreatitis presented to an outside hospital for abdominal pain, nausea, and vomiting. His initial laboratory results were notable for a lipase of 4000 U/L and acute kidney injury with creatinine of 1.6 mg/dL. The patient had a computed tomography (CT) of the abdomen and pelvis showing peripancreatic fat stranding suggestive of acute pancreatitis. After several days, the patient developed a fever and was placed on piperacillin-tazobactam. Blood cultures obtained before the initiation of antibiotics grew out Klebsiella pneumoniae. Because of continued fevers, a repeat CT scan was performed, which showed the development of a pancreatic abscess (Fig. 1A) . Repeat laboratory results were within reference limits except for an elevated total bilirubin of 2.5 mg/dL and an alkaline phosphatase level of 210 U/L. A third CT scan showed extensive pancreatic inflammation and air consistent with EP and an abscess in the lesser sac measuring 6.6 Â 4.7 cm. At this point, his antibiotic was switched to meropenem, and he was transferred to our facility.
Upon arrival, the patient had a heart rate of 102 beats per minute with otherwise normal vital signs. He was still complaining of abdominal pain, nausea, and vomiting and, on examination, had epigastric tenderness to palpation without rebound or guarding. Abnormal laboratory results included a leukocytosis of 16,500 Â 10 3 /μL, alkaline phosphatase of 296 U/L, and an albumin of 2.0 g/dL. Amylase and lipase were both 10 U/L. A CT scan at our facility showed progression of his EP with pseudocyst formation along the anterior aspect of the pancreatic tail (Fig. 2B) . Because the patient remained hemodynamically stable, the decision was made to defer intervention on his pancreas, and he was discharged on levofloxacin and metronidazole. Two months after his initial arrival at our hospital, he underwent an upper endoscopic ultrasound showing a 70-mm single-compartment, thick-walled pancreatic cyst without septae in the pancreas, which was endoscopically drained. An endoscopic necrosectomy with removal of residual necrotic debris was also performed ( Figs. 2A-F) . He tolerated the procedure well without any postprocedural complications. Cultures from these procedures grew out Candida glabrata and K. pneumoniae, and he was discharged on a course of trimethoprim-sulfamethoxazole, metronidazole, and fluconazole. A subsequent CT scan showed complete resolution of the pancreatic necrosis (Fig. 1C) . He continued to follow-up in our clinic, gained 10 lb, and did not require further hospitalizations for pancreatitis.
MATERIALS AND METHODS
A PubMed search was performed to identify previous cases of EP using the search terms "emphysematous pancreatitis"; "pancreatitis, gas"; "acute necrotizing pancreatitis, gas"; "acute necrotizing pancreatitis, emphysema"; and "acute necrotizing pancreatitis, abscess." All reports that were published before September 2015 were identified and reviewed. Cases that met the inclusion criteria (the presence of gas in the pancreas demonstrated either radiographically or on postmortem analysis in the setting of symptoms of acute pancreatitis) were included. Data on age, sex, report date, symptoms and vitals on presentation, existing comorbidities (diabetes mellitus, history of pancreatitis or cardiac disease, and previous abdominal surgery), alcohol use, imaging findings, serum leukocyte count, liver function tests, amylase and lipase levels, hemoglobin levels, microbiology results, use of antimicrobial agents, percutaneous and surgical interventions, the presence of organ failure, mortality, and length of stay were collected. Cases of EP that occurred after instrumentation or drug-induced cases were excluded from the analysis.
A systematic analysis was performed using the data obtained from previously reported cases and a recent case from our center. Statistical analysis was completed using SPSS v22.0 (SPSS Inc, Chicago, Ill). χ 2 and Fisher's exact tests were used for categorical data. t-test was used for parametric testing, and Mann-Whitney U test was used for nonparametric testing when appropriate. Subsequently, a multivariate logistic regression analysis was completed to determine the predictors of survival.
RESULTS

Literature Search
We identified 63 cases of EP fitting criteria through our literature search. With the addition of our case, the study size reached 64 subjects.
Baseline Demographics of the Study Population
The mean (standard deviation, SD) age of study population was 60.3 (15.7) years. The study cohort included 13 women and 50 men, with 1 case not specifying sex. The mean (SD) duration of symptoms before presentation was 5.6 (11.5) days. Fifty-nine percent of the subjects had history of alcohol use, 47.8% had diabetes, 30% had previous abdominal surgery, 20 .8% had a previous episode of pancreatitis, and 15% had gallstones. Information on race was not available.
Clinical Characteristics of EP Subjects Who Died During Hospitalization Versus Discharged
Of the 64 cases included in our analysis, 21 patients died during hospitalization, resulting in an overall mortality of 32.8%. Age was significantly higher in EP subjects who died compared with EP subjects who survived (mean [SD], 66.9 [13.7] vs 57.1 [16.9] years, P = 0.019) (Fig. 3 ). There were no significant differences in regard to sex (P = 0.19), history of diabetes mellitus (P = 0.56), alcohol abuse (P = 0.33), previous pancreatitis (P = 0.32), or abdominal surgery (P = 0.48) among those who survived versus died (Fig. 3) .
As shown in Table 1 , the following categorical variables were seen in significantly higher number of subjects who died compared with those who were discharged: gas outside the pancreas (86.7% vs 40.6%, P = 0.003), the development of hypotension (58.3% vs 10.5%, P = 0.007), multiorgan failure (92.3% vs 43.8%, P = 0.008), and initial surgical intervention (71.4% vs 35.0%, P = 0.007). The cohort of patients who survived was significantly more likely to undergo initial percutaneous drainage than those who did not (50% vs 15%, P = 0.008). There was a trend toward increased frequency of acute kidney injury (P = 0.06) in subjects who did not survive, whereas the presence of 2 or more Systemic Inflammatory Response Syndrome (SIRS) criteria (P = 0.42) did not differ between the 2 groups. There were no significant differences in the frequency of hyperbilirubinemia In regard to management, subjects who were given a diagnosis of EP after the publication of American College of Gastroenterology (ACG) guidelines in 2013 had initial percutaneous intervention more often compared with subjects given a diagnosis of EP before 2013 (71.4% vs 29.3%, P = 0.007). Microbiological data of pancreatic fluid samples were available in 40 of 64 patients ( Table 2 ). The most commonly identified organisms were Escherichia coli (n = 14) and Clostridium perfringens (n = 12). Of the cases with available data, 9 subjects had more than 1 organism grown on pancreatic fluid culture. There was no significant association between types of identified organisms on blood culture (P = 0.55) or pancreatic tissue cultures (P = 0.30) and mortality. Of the cases with antibiotic information available, 100% were treated with antibiotics against gram-negative organisms, and 93% were treated for gram-positive organisms. Too few cases reported data on duration of antibiotics and length of time to initiation of antibiotics; therefore, no additional analysis was performed.
Predictors of Mortality
A multivariate logistic regression analysis was performed to identify possible variables associated with mortality. The following variables were used in the multivariate analysis using entry method: age, sex, multiorgan failure, initial percutaneous drainage, and initial surgical drainage. Because of missing data, 27 subjects remained in the final analysis. Among these variables, only the development of multiorgan failure was found to be a significant predictor of mortality (P = 0.038), whereas age (P = 0.059), initial percutaneous drainage (P = 0.999), initial surgical drainage (P = 0.708), and sex (P = 0.999) were not.
DISCUSSION Pathogenesis
Emphysematous pancreatitis is characterized by the presence of gas in and/or around the pancreas in the setting of infected pancreatic tissue. The most common organisms associated with EP are gram-negative anaerobes including E. coli, Pseudomonas aeruginosa, K. pneumoniae, and Acinetobacter species, 14 ,16 with C. perfringens being the most common gram-positive pathogen. [17] [18] [19] Infectious organisms can translocate into the pancreas via hematogenous or lymphatic dissemination or biliopancreatic reflux 20 or through direct translocation through enteropancreatic fistulas. 14 Patients with diabetes are thought to be at an increased risk because of their impaired host vascular and tissue response 21 and their hyperglycemic state, which allows gas-producing organisms to ferment glucose into carbon dioxide and hydrogen gas.
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Diagnosis and Differential
Before the advent of CT, cases were either diagnosed via x-ray, intraoperatively, or postmortem. An x-ray showing gas in the abdomen is a relatively nonspecific finding because this gas can be intraluminal or extraluminal gas. Findings suggestive of EP on x-ray are extrinsic compression of the stomach, increased distance between the stomach and transverse colon, and presence of nonconvalescing gas bubbles on serial imaging. 22, 23 Currently, most cases of EP are diagnosed via CT imaging. 19 Parenchymal nonenhancement accompanied by multiloculated gas is essentially diagnostic of infected pancreatic necrosis (IPN). 24 Although CT contrast is not needed to diagnose air in the pancreas, it can help to diagnose complications of IPN and abscess formation. 12, 25 The classic radiological finding associated with EP is gas in and around the pancreas, commonly in the lesser sac. 14 However, air in the pancreas in itself is not diagnostic of EP. There are several other causes of air in the pancreas that should Data were presented as n (%) unless otherwise indicated. The percentages (in parentheses) are based on subjects in each group who had available data on these particular variables. be considered because these tend to have a more benign course and require less aggressive management. 11, 25 The most common mimicker of EP is the presence of an enteropancreatic fistula. This can often occur in the setting of a ruptured pancreatic pseudocyst or as a complication of phlegmonous pancreatitis. These fistulas, when connected to the gastrointestinal lumen at the duodenum, jejunum, or colon, can themselves lead to pancreatic infection. 12, 25, 26 When suspected, fluoroscopy or imaging using water-soluble contrast material can be used to evaluate for this possibility. Other noninfectious etiologies of air in the pancreas include pancreatic biopsy, 27, 28 gallstone pancreatitis, 29 surgical instrumentation or therapeutic embolization of malignancies, 30 duodenal diverticulum, a patent ampulla of Vater, and penetrating duodenal ulcers. 14 The collections of gas in the setting of an abscess tend to have a mottled appearance on CT, whereas gas in the setting of therapeutic tissue embolization can have a more linear or branching pattern. 30 
Treatment Options
Although intravenous fluids and pain control have been accepted as the mainstay of acute pancreatitis treatment for many years, the use of interventional procedures for complicated acute pancreatitis cases has evolved for the past couple decades. In previous years, it was felt that gas in and around the pancreas required emergent surgical operation. However, in the early 2000s, several studies showed that percutaneous drainage was associated with decreased mortality when compared with open necrosectomy for ANP. [31] [32] [33] Subsequent investigations suggested that medical management alone without any procedural intervention could even be considered in certain cases of IPN. 10, 13, 16, 34, 35 Since then, there have been numerous publications supporting a conservative management strategy for IPN. 36, 37 Unfortunately, because of the rarity of the condition, none of these published articles have looked exclusively at EP.
Because EP is a subset of IPN, treatment should consist of antibiotics in addition to intravenous fluids, pain control, and nutritional support, with percutaneous intervention being determined on a case-by-case basis. In stable patients with infected necrosis, drainage should be delayed preferably for at least 4 weeks to allow for liquefaction of the contents and the development of walled-off necrosis. 38 In patients who have refractory symptoms or other indications for emergent surgery such as catastrophic intra-abdominal hemorrhage, visceral perforation, or the development of abdominal compartment syndrome, minimally invasive surgery is preferred to open necrosectomy. 39 
Expected Outcomes
Outcomes with IPN have drastically improved with the advent of broad-spectrum antibiotics and other supportive care equipment. Mortality rates with IPN have decreased from 80% in the 1980s 40 to the current rate of 8%. 41 In the largest study of Wig et al 14 comparing EP and IPN (11 cases of EP and 46 cases of IPN), no statistically significant difference in the rate of mortality was found between the 2 groups of patients. In Wig et al's 14 study, the authors found a 36% mortality rate of EP, whereas in Nadkarni et al 16 study, the authors found a 10% mortality rate. The difference in survival rate between these studies is most likely related to the difference in percentage of surgical intervention because, in the Wig et al 14 study, 100% of patients underwent surgical intervention, whereas in the Nadkarni et al 16 study, only 11% underwent surgery. The patients were otherwise similar in CT severity index, age, sex, and microorganisms isolated. The overall mortality rate in our study was 32.8%, and the mortality rate was significantly decreased in patients undergoing initial percutaneous drainage compared with those undergoing initial surgical management (15% vs 71.4%, P = 0.007). Our findings further corroborate the decreased mortality in patients initially managed with percutaneous drainage found in the previous 2 studies. 14, 16 In 2010, a landmark study by van Santvoort et al 37 was published in the New England Journal of Medicine, which showed a statistically significant decrease in mortality using a step-up approach to ANP. In 2013, the ACG used this study as part of the evidence supporting the new guidelines for the management of acute pancreatitis, which recommended avoidance of surgical intervention. 2 Our analysis showed that patients given a diagnosis of EP after the 2013 ACG guidelines 2 were released were significantly more likely to undergo initial percutaneous intervention compared with initial surgery (71.4% vs 29.3%, P = 0.007).
Study Findings
Although older age, the development of multiorgan failure, initial surgical intervention, and gas both in and outside the pancreas were associated with increased mortality in the univariate analysis, the only independent predictor of mortality in the multivariate analysis was multiorgan failure. In our study, a history of diabetes mellitus was not associated with increased mortality. However, we noted that patients without a documented history of diabetes who developed hyperglycemia during their acute illness (n = 9) had 100% mortality. There are 2 hypotheses to explain this finding. The first possible explanation is that patients with new-onset hyperglycemia during acute pancreatitis had a larger percentage of pancreatic necrosis causing dysregulation of glucose levels. Unfortunately, too few cases included information about percentage of pancreatic necrosis for us to quantify it during our analysis. The second explanation is related to the known phenomenon of hyperglycemia in the setting of severe sepsis. Although the mortality rate in cases with hyperglycemia was higher than the overall mortality rate (64% vs 32.8%), too few cases reported data on hyperglycemia to allow us to perform a meaningful statistical analysis.
Upon analysis of microbiology, no single organism was associated with increased mortality. As shown in Table 2 , most bacteria isolated were gram-negative enteric organisms. Unexpectedly, almost half of the cases had gram-positive organisms present on culture, most commonly C. perfringens. The vast majority of patients were placed on broad-spectrum antibiotics both against gram-negative and gram-positive organisms. Unfortunately, there were no sufficient data to evaluate time to initiation and duration of antibiotics.
Limitations
There are several limitations to our study. First, despite our review being the most comprehensive to date, the study size remains small, and this may lead to decreased power to detect variables that could affect survival. Second, there may be other factors that we could not analyze because of the retrospective design of our study and lack of data in previously published case reports. Third, the data we collected provide a time point analysis only, and we do not have any long-term follow-up data.
CONCLUSIONS
Emphysematous pancreatitis is a subtype of ANP with resultant gas formation and systemic toxicity. It has been associated with high rates of morbidity and mortality in the past and has been decreasing for the past decade, as confirmed by our study. Through our comprehensive systematic analysis, we revealed that management of EP has shifted from early surgery toward more conservative measures including advanced supportive care and earlier interventions including percutaneous drainage and endoscopic therapy.
